Related content

Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis

By Mader I.  

Brain, Vol. 124, Iss. 5, 2001-05 ,pp. : 953-961

Oxford University Press

Access to resources Recommend Favorite

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

By Miller D.H.  

Brain, Vol. 125, Iss. 8, 2002-08 ,pp. : 1676-1695

Oxford University Press

Access to resources Recommend Favorite

Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients

By Sarchielli P   Presciutti O   Pelliccioli GP   Tarducci R   Gobbi G   Chiarini P   Alberti A   Vicinanza F   Gallai V  

Brain, Vol. 122, Iss. 3, 1999-03 ,pp. : 513-521

Oxford University Press

Access to resources Recommend Favorite

Brain atrophy in clinically early relapsing–remitting multiple sclerosis

By Chard D.T.   Griffin C.M.   Parker G.J.M.   Kapoor R.   Thompson A.J.   Miller D.H.  

Brain, Vol. 125, Iss. 2, 2002-02 ,pp. : 327-337

Oxford University Press

Access to resources Recommend Favorite

Reliable measurements of brain atrophy in individual patients with multiple sclerosis

By  

Brain And Behavior, Vol. 6, Iss. 9, 2016-09 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite